Transitional Cell Cancer of the Renal Pelvis and Ureter Not Yet Recruiting Phase 2 / 3 Trials for Camrelizumab (DB14776)

Also known as: Transitional Cell Cancer of Renal Pelvis and Ureter / Transitional Cell Tumor / Transitional cell carcinoma of upper urinary tract (disorder) / Transitional cell cancer of the renal pelvis and ureter NOS / Renal pelvis and ureter transitional cell cancer NOS / Renal pelvis and ureteric cancer NOS transitional cell / Renal pelvis and ureteral cancer transitional cell NOS / Renal pelvis and ureteric cancer transitional cell NOS

IndicationStatusPhase
DBCOND0028512 (Transitional Cell Cancer of the Renal Pelvis and Ureter)Not Yet Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05322187Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After ChemotherapyTreatment